Jade Biosciences (JBIO) Treasury Shares (2020 - 2026)
Jade Biosciences (JBIO) posted Treasury Shares of $307142.0 for Q1 2026, down 9.52% on a QoQ basis from $339473.0 in Q4 2025, and down 98.46% year-over-year from $20.0 million in Q1 2025.
Jade Biosciences (JBIO) Treasury Shares (2020 - 2026) Analysis & Trends
Jade Biosciences' Treasury Shares history runs 7 years deep, the most recent figure standing at $307142.0 for Q1 2026.
- Quarterly Treasury Shares fell 98.46% year-over-year to $307142.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $307142.0 (down 98.46% YoY) and the FY2025 annual result came in at $339473.0, down 98.3% from the prior year.
- Treasury Shares was $307142.0 for Q1 2026 at Jade Biosciences, down from $339473.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $28.9 million in Q4 2022 and bottomed at $19192.0 in Q1 2024.
- A 5-year average of $6.5 million and a median of $307142.0 in 2026 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares slumped 99.92% — and 2025, when it surged 104110.09%.
- Jade Biosciences' Treasury Shares stood at $28.9 million in 2022, then slumped by 99.92% to $21968.0 in 2023, then soared by 90941.51% to $20.0 million in 2024, then tumbled by 98.3% to $339473.0 in 2025, then dropped by 9.52% to $307142.0 in 2026.
- Business Quant data shows JBIO's Treasury Shares at $307142.0 in Q1 2026, $339473.0 in Q4 2025, and $371804.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | 307,142.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 307,142.00 |
| Mar 31, 2026 | 307,142.00 |
| Dec 31, 2025 | 339,473.00 |
| Dec 31, 2025 | 339,473.00 |
| Sep 30, 2025 | 371,804.00 |
| Sep 30, 2025 | 371,804.00 |
| Jun 30, 2025 | 495,739.00 |
| Jun 30, 2025 | 495,739.00 |
| Mar 31, 2025 | 20.00 Mn |
| Mar 31, 2025 | 20.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | 20.00 Mn |
| Sep 30, 2024 | 20.00 Mn |
| Jun 30, 2024 | 20.00 Mn |
| Jun 30, 2024 | 20.00 Mn |
| Mar 31, 2024 | 19,192.00 |
| Mar 31, 2024 | 19,192.00 |
| Dec 31, 2023 | 21,968.00 |
| Dec 31, 2023 | 21,968.00 |